Population pharmacokinetic model of irinotecan and its four main metabolites in patients treated with FOLFIRI or FOLFIRINOX regimen.
Laure DeymeDominique BarbolosiLitaty Céphanoée MbatchiNicole Tubiana-MathieuMarc YchouAlexandre EvrardFlorence GattaccecaPublished in: Cancer chemotherapy and pharmacology (2021)
ClinicalTrials.gov identifier: NCT00559676.